Knight Therapeutics and SIFI S.p.A. Announce Filing of New Drug Submission for NETILDEX(TM) in Canada(TM)
MONTREAL, QUEBEC--(Marketwired - Feb 15, 2018) - Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, and S.I.F.I- Società Industria Farmaceutica Italiana S.p.A. ("SIFI"), a prominent …